An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer
Sign Up to like & getrecommendations! Published in 2023 at "Advanced Science"
DOI: 10.1002/advs.202206756
Abstract: Pancreatic ductal adenocarcinoma rapidly acquires resistance to chemotherapy, remaining a fatal disease. Immunotherapy is one of the breakthroughs in cancer treatment, which includes immune checkpoint inhibitors, chimeric antigen receptor T‐cell immunotherapy, and neoantigen vaccines. However,… read more here.
Keywords: liquid ablation; pancreatic cancer; ablation; ionic liquid ... See more keywords